Early Renal Abnormalities as an Indicator of Cardiovascular Risk in Type 2 Diabetes

High Blood Pressure and Cardiovascular Prevention

Volumn 21, Issue 4, 2014, Pages 257-260

  Viazzi, Francesca ^a   Bonino, Barbara ^a   Ratto, Elena ^a   De Cosmo, Salvatore ^b   Pontremoli, Roberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Scientific Institute   (Italy)

Author keywords

Cardiovascular risk; Chronic kidney disease; Diabetes; Glomerular filtration rate; Microalbuminuria

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER;

ALBUMINURIA; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DIABETIC PATIENT; END STAGE RENAL DISEASE; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; KIDNEY FUNCTION; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; RISK ASSESSMENT; RISK FACTOR; URINARY EXCRETION; CARDIOVASCULAR DISEASES; COMPLICATION; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TEST; PATHOPHYSIOLOGY; PROGNOSIS;

ALBUMINURIA; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 84916596590     PISSN: 11209879     EISSN: 11791985     Source Type: Journal    
DOI: 10.1007/s40292-014-0067-y     Document Type: Article

References (26)

1. ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;2013(31):1925–38.
2. Viazzi F, Leoncini G, Parodi D, Ratto E, Vettoretti S, Vaccaro V, Parodi A, Falqui V, Tomolillo C, Deferrari G, Pontremoli R. Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension. J Am Soc Nephrol. 2005;16(Suppl 1):S89–91.
3. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR. UKPDS Group Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003;63:225–32.
4. Haynes R, Staplin N, Emberson J, Herrington GW, Tomson C, Agodoa L, Tesar V, Levin A, Lewis D, Reith C, Baigent C, Landray MJ, SHARP Collaborative Group. Evaluating the Contribution of the Cause of Kidney Disease to Prognosis in CKD: Results From the Study of Heart and Renal Protection (SHARP). Am J Kidney Dis. 2014;64:40–8.
5. Fox CS, Matsushita K, Woodward M, Bilo HJ, Chalmers J, Heerspink HJ, Lee BJ, Perkins RM, Rossing P, Sairenchi T, Tonelli M, Vassalotti JA, Yamagishi K, Coresh J, de Jong PE, Wen CP, Nelson RG, Chronic Kidney Disease Prognosis Consortium. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet. 2012;380(9854):1662–73.
6. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU. The definition, classification and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 2011;80:17–28.
7. Leoncini G, Viazzi F, Pontremoli R. Overall health assessment: a renal perspective. Lancet. 2010;375(9731):2053–4.
8. Ekinci EI, Jerums G, Skene A, Crammer P, Power D, Cheong KY, Panagiotopoulos S, McNeil K, Baker ST, Fioretto P. Macisaac RJ Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function. Diabetes Care. 2013;36:3620–6.
9. De Cosmo S, Rossi MC, Pellegrini F, Lucisano G, Bacci S, Gentile S, Ceriello A, Russo G, Nicolucci A, Giorda C, Viazzi F, Pontremoli R, AMD-Annals Study Group. Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes. Nephrol Dial Transplant. 2014;29:657–62.
10. Pugliese G, Solini A, Fondelli C, Trevisan R, Vedovato M, Nicolucci A, Penno G, Renal Insufficiency and Cardiovascular Events (RIACE) Study Group. Reproducibility of albuminuria in type 2 diabetic subjects. Findings from the Renal Insufficiency and Cardiovascular Events (RIACE) study. Nephrol Dial Transplant. 2011;26:3950–4.
11. Solini A, Penno G, Bonora E, Fondelli C, Orsi E, Arosio M, Trevisan R, Vedovato M, Cignarelli M, Andreozzi F, Nicolucci A, Pugliese G, Renal Insufficiency and Cardiovascular Events (RIACE) Study Group. Diverging association of reduced glomerular filtration rate and albuminuria with coronary and noncoronary events in patients with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. Diabetes Care. 2012;35:143–9.
12. Tonelli M, Muntner P, Lloyd A, Manns BJ, James MT, Klarenbach S, Quinn RR, Wiebe N, Hemmelgarn BR, Alberta Kidney Disease Network. Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease. A cohort study. Ann Intern Med. 2011;154:12–21.
13. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. 1982;1(8287):1430–2.
14. De Zeeuw D, Parving HH, Henning RH. Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol. 2006;17:2100–5.
15. Viazzi F, Garneri D, Leoncini G, Gonnella A, Muiesan ML, Ambrosioni E, Costa FV, Leonetti G, Pessina AC, Trimarco B, Volpe M, Agabiti Rosei E, Deferrari G, Pontremoli R. Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: insights from the I-DEMAND study. Nutr Metab Cardiovasc Dis. 2014. doi:10.1016/j.numecd.2014.01.018. [Epub ahead of print].
16. Leoncini G, Viazzi F, Parodi D, Vettoretti S, Ratto E, Ravera M, Tomolillo C, Del Sette M, Bezante GP, Deferrari G, Pontremoli R. Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension. Hypertension. 2003;42:14–8.
17. Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, Patel A, Cass A, Neal B, Poulter N, Mogensen CE, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Macmahon S, Chalmers J, ADVANCE Collaborative Group. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 2009;20:1813–21.
18. Marshall SM. Natural history and clinical characteristics of CKD in type 1 and type 2 diabetes mellitus. Adv Chronic Kidney Dis. 2014;21:267–72.
19. Ruggenenti Piero, Porrini Esteban, Motterlini Nicola, Perna Annalisa, Ilieva Aneliya Parvanova, Iliev Ilian Petrov, Dodesini Alessandro Roberto, Trevisan Roberto, Bossi Antonio, Sampietro Giuseppe, Capitoni Enrica, Gaspari Flavio, Rubis Nadia, Ene-Iordache Bogdan, Remuzzi Giuseppe, BENEDICT Study Investigators. Measurable urinary albumin predicts cardiovascular risk among normoalbuminuric patients with type 2 diabetes. J Am Soc Nephrol. 2012;23:1717–24.
20. Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlöf B, Snapinn SM, Wan Y, Lyle PA. Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study. Diabetes Care. 2006;29:595–600.
21. Schmieder RE, Mann JF, Schumacher H, Gao P, Mancia G, Weber MA, McQueen M, Koon T, Yusuf S, ONTARGET Investigators. Changes in albuminuria predict mortality and morbidity in patients with vascular disease. J Am Soc Nephrol. 2011;22:1353–64.
22. Savarese G, Dei Cas A, Rosano G, D’Amore C, Musella F, Mosca S, Reiner MF, Marchioli R, Trimarco B, Perrone-Filardi P. Reduction of albumin urinary excretion is associated with reduced cardiovascular events in hypertensive and/or diabetic patients. A meta-regression analysis of 32 randomized trials. Int J Cardiol. 2014;172:403–10.
23. Penno G, Solini A, Bonora E, Fondelli C, Orsi E, Zerbini G, Trevisan R, Vedovato M, Gruden G, Cavalot F, Cignarelli M, Laviola L, Morano S, Nicolucci A, Pugliese G, Renal Insufficiency and Cardiovascular Events (RIACE) Study Group. Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. J Hypertens. 2011;29:1802–9.
24. Pugliese G, Solini A, Bonora E, Orsi E, Zerbini G, Fondelli C, Gruden G, Cavalot F, Lamacchia O, Trevisan R, Vedovato M, Penno G, RIACE Study Group. Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. Cardiovasc Diabetol. 2014;13:59. doi:10.1186/1475-2840-13-59.
25. Haller H, Menne J, Mancia G. Awareness and behaviour of European physicians in relation to microalbuminuria and organ damage: an ESH-endorsed survey. J Hypertens. 2010;28:2204–9.
26. Ko SH, Kwon HS, Kim DJ, Kim JH, Kim NH, Kim CS, Song KH, Won JC, Lim S, Choi SH, et al. Higher prevalence and awareness, but lower control rate of hypertension in patients with diabetes than general population: the fifth Korean national health and nutrition examination survey in 2011. Diabetes Metab J. 2014;38:51–7.